Alaina – Interview 05
Alaina was diagnosed with CIN 2 / 3 in 2008, aged 25. She had severe bleeding a few days after having treatment and was rushed to hospital, where she was treated and stayed for a day. She has been well since then.
When Alaina was invited for routine cervical screening, the GP surgery was so busy it took a while before she was actually given a test at a local clinic. Alaina said, I was pretty much ready to give up by that point, but I actually worked at a cancer charity in Malaysia on my gap year, and I worked on producing leaflets for them, so I knew the importance of it. So I persevered.;
The first test she was given was unclear and she was asked to come back for another one. The results showed that she had mild cell changes and would need to have another test in six months time. These results showed that she had mild to moderate changes and, again, would need another smear test six months later.
The next test showed moderate to severe changes and Alaina was referred to a colposcopy clinic. She had a colposcopy and biopsy and was told that it looked like HPV and nothing to worry about. The results, however, showed that she needed treatment. Alaina was unsure whether she had CIN 2 or CIN 3. At another appointment, Alaina had a LLETZ. The procedure was painless, she felt well and went back to work the following day.
When Alaina was out at the weekend, she said she started haemorrhaging. She was bleeding extremely heavily and was very frightened. It was late at night and she took a taxi to the Accident and Emergency department of the hospital to which she had been advised to go should this occur. She was on her own and had to wait until a gynaecologist could see her. She was treated with a chemical that she did not know the name of and the bleeding soon stopped. Alaina stayed in hospital overnight and for the next day.
Alaina said she would have liked more information on what to expect after treatment, particularly on how much bleeding is normal and when to be concerned. She would have also liked more information on aftercare, follow-up care and HPV.